Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
SBB-CE0055-C050 | 50 µg | - | - |
3 - 9 business days* |
639.00€
|
Protein. Human Parkin (Accession Nr. O60260) is fused at the N-terminus to a His-tag. Source: Sf9... more
Product information "Parkin (E3 Ligase) (human) (rec.) (His)"
Protein. Human Parkin (Accession Nr. O60260) is fused at the N-terminus to a His-tag. Source: Sf9 cells. Liquid. In 50mM Tris-HCl pH 8.0, 200mM sodium chloride, 10% glycerol, 5mM TCEP. Purity: >95% (SDS-PAGE). Parkin (Parkinson juvenile disease protein 2) is a ~52kDa E3 Ligase enzyme protein, encoded by the PARK2 gene. It plays an important role in the ubiquitin-proteasome system and acts as a regulator of protein breakdown. Parkin is located in the cytoplasma until a sustained depolarization occurs after which it is translocated to the mitochondrial membrane and induces the degradation of various membrane proteins. Parkin mutation leads to the accumulation of missfolded, aggregated proteins and degenerated mitochondria. The role of these changes in the pathomechanism of neurodegenerative diseases is well-known. Parkin mutation is responsible for about 50% of familial cases and for 10 to 20% of youth cases. Present views are that the improper regulation of protein aggregation and a dysfunction of the ubiquitin-proteasome system may be the common pathway of sporadic and hereditary Parkinson's disease. In vitro, Parkin can be activated by treatment with recombinant PINK1, or addition of low concentrations of pS65-phosphoubiquitin. Parkin has been reported to generate poly-Ubiquitin chains in K6, K11, K48, and K63 linkages both in vitro and in vivo.
Keywords: | PARK2, E3 Ubiquitin-protein Ligase Parkin, Parkinson Disease Protein 2, PRKN, Parkin, Parkinson disease protein 2, E3 ubiquitin-protein ligase parkin, Parkinson juvenile disease protein 2, Parkin RBR E3 ubiquitin-protein ligase |
Supplier: | South Bay Bio |
Supplier-Nr: | CE0055 |
Properties
Conjugate: | No |
Host: | Sf9 cells |
MW: | 52 kD |
Purity: | >95% (SDS-PAGE) |
Format: | Liquid |
Database Information
KEGG ID : | K04556 | Matching products |
UniProt ID : | O60260 | Matching products |
Gene ID | GeneID 5071 | Matching products |
Handling & Safety
Storage: | -80°C |
Shipping: | -20°C (International: -20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed